Drug Pain

Nurtec Odt

Payments companies reported to CMS as associated with Nurtec Odt. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.

$15Massociated payments (2023-2025)

103,365clinicians with associated payments

8companies reporting

By year

2023 $4.1M

2024 $4.3M

2025 $6.4M

Payments reported as associated with Nurtec Odt, per program year, as reported to CMS.

Who makes it

Specialties most often involved

Neurology (Psychiatry & Neurology) $3.8M

Family Medicine $2.7M

Family $2.0M

Internal Medicine $1.8M

Physician Assistant $904K

Nurse Practitioner $604K

Where the associated payments went, by the receiving clinician's specialty.

Clinicians most associated with Nurtec Odt

These are the largest totals companies reported as associated with Nurtec Odt. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.

Clinician	Location	Specialty	Associated payments (2023-2025)
Stewart Tepper	Stamford, CT	Neurology (Psychiatry & Neurology)	$207,851.52
Peter Goadsby	Los Agneles, CA	Neurology (Psychiatry & Neurology)	$122,164.79
Jessica Ailani	Washington, DC	Neurology (Psychiatry & Neurology)	$100,793.94
Noah Rosen	Great Neck, NY	Neurology (Psychiatry & Neurology)	$70,596.87
Fred Cohen	Bronx, NY	Pain Medicine (Psychiatry & Neurology)	$65,190.37
Richard Lipton	Bronx, NY	Neurology (Psychiatry & Neurology)	$64,824.72
Wade Cooper	Ann Arbor, MI	Neurology (Psychiatry & Neurology)	$55,767.31
Hope O'Brien	Cincinnati, OH	Neurology With Special Qualifications In Child Neurology	$54,877.78
Vincent Martin	Cincinnati, OH	Internal Medicine	$51,603.24
Traci Purath	Burlington, WI	Neurology (Psychiatry & Neurology)	$49,290.62

Prescribed Nurtec Odt?

See what its makers reported for your doctor. Two steps, private, no account.

Check my doctor

What this means, and what it doesn't

These payments are legal and common. Drug and device makers routinely pay for meals at educational events, consulting, speaking, travel, and research. Companies are required by federal law to report them; that's why this data exists.
A payment is not evidence of wrongdoing. Most clinicians who accept industry payments provide excellent care. Research payments in particular often reflect participation in clinical trials.
Context beats raw numbers. A few hundred dollars in sandwiches over several years is typical. What's worth understanding is scale, source, and purpose, which is what this page shows.
The data comes from companies, not doctors. Figures are "as reported to CMS" by the paying companies. Clinicians can dispute records through CMS's official process.

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.